Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cells|January 11, 2024
Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer TherapyDaniela Spano, Giuliana Catara
Frontiers in Oncology|August 12, 2021
Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem CellsGiuliana Catara, Antonino Colanzi, Daniela Spano
Frontiers in Oncology|September 6, 2021
Corrigendum: Combinatorial Strategies to Target Molecularand Signaling Pathways to Disarm Cancer Stem CellsGiuliana Catara, Antonino Colanzi, Daniela Spano
Scientific Reports|October 27, 2017
PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functionsGiuliana Catara, Giovanna Grimaldi, Laura Schembri, et al.
Frontiers in Bioscience (Landmark Edition)|January 2, 2015
From toxins to mammalian enzymes: the diversity of mono-ADP-ribosylationGiovanna Grimaldi, Daniela Corda, Giuliana Catara
Pathogens (Basel, Switzerland)|February 25, 2023
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial StrategiesGiuliana Catara, Rocco Caggiano, Luca Palazzo
Biomolecules|March 25, 2022
ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological PerspectivesGiuseppe Manco, Giuseppina Lacerra, Elena Porzio, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2018
In Vitro Techniques for ADP-Ribosylated Substrate IdentificationGiovanna Grimaldi, Giuliana Catara, Carmen Valente, et al.
Biochemical Pharmacology|February 6, 2026
The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncologyGiuliana Catara, Gaetano Gerace, Raffaella Lauro, et al.
Biochemical Pharmacology|June 10, 2019
Targeting ADP-ribosylation as an antimicrobial strategyGiuliana Catara, Annunziata Corteggio, Carmen Valente, et al.
Pageof 6